{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:08:49Z","timestamp":1792782529662,"version":"4.5.0"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Prader-Willi Syndrome Association","id":[{"id":"https:\/\/ror.org\/05wry3s62","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Individuals with Prader\u2013Willi Syndrome (PWS) are at increased risk for developing behavioral and psychiatric disorders, often requiring antipsychotics (APs). Contrary to significant AP\u2010associated weight gain observed in the general population, existing literature suggests weight loss in patients with PWS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Objective<\/jats:title>\n                    <jats:p>To evaluate the relationship between AP use and body mass index (BMI) at admission, change in BMI during inpatient stay, and length of stay (LOS) in patients admitted to an inpatient PWS treatment program.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective case\u2010control study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Hospital\u2010based, inpatient PWS treatment program serving nationally and internationally referred children and adults with PWS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Cases consisted of 52 pediatric patients with PWS who were taking APs at admission and during their stay, 97 adults with PWS who were taking APs at admission and during their stay, and 11 pediatric and adult patients with PWS who were AP na\u00efve at admission and subsequently started an AP during their stay; all cases were matched with patients with PWS who were AP na\u00efve at admission and during their stay by age (yrs), sex, and race\u2010ethnicity (controls).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>\n                      Between\u2010 and within\u2010group differences in admission BMI, BMI change from admission to discharge, and LOS were analyzed. Admission BMI was lower (mean\u00a0\u00b1\u00a0SD 36.8\u00a0\u00b1\u00a011.9\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      vs 46.7\u00a0\u00b1\u00a012.5\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , p&lt;0.001) and LOS longer (mean\u00a0\u00b1\u00a0SD 75.9\u00a0\u00b1\u00a038.5\u00a0days vs 57.8\u00a0\u00b1\u00a023.2\u00a0days, p=0.005) for pediatric cases with AP exposure at admission and during their stay compared with matched controls. All groups experienced significant decreases in BMI from admission to discharge (p\u22640.001 for all comparisons), except for pediatric cases with AP exposure at admission and during their stay. Cases that were AP na\u00efve at admission and subsequently started an AP during their inpatient stay experienced a significantly smaller decrease in BMI from admission to discharge than matched controls (\u22123.011 vs \u22127.288\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , p=0.027). No other comparisons between cases and controls were significantly different.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>On average, patients with PWS who were prescribed APs lost weight during their inpatient stay, but this varied with patient age and duration of AP use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/phar.1558","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T16:05:48Z","timestamp":1427213148000},"page":"260-268","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Relationship between Antipsychotics and Weight in Patients with Prader\u2013Willi Syndrome"],"prefix":"10.1002","volume":"35","author":[{"given":"Jennifer Padden","family":"Elliott","sequence":"first","affiliation":[{"name":"Mylan School of Pharmacy Duquesne University Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Cherpes","sequence":"additional","affiliation":[{"name":"Center for Prader\u2013Willi Syndrome The Children's Institute of Pittsburgh Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Kamal","sequence":"additional","affiliation":[{"name":"Mylan School of Pharmacy Duquesne University Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishveen","family":"Chopra","sequence":"additional","affiliation":[{"name":"Mylan School of Pharmacy Duquesne University Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Harrison","sequence":"additional","affiliation":[{"name":"Mylan School of Pharmacy Duquesne University Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Riedy","sequence":"additional","affiliation":[{"name":"Mylan School of Pharmacy Duquesne University Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Herk","sequence":"additional","affiliation":[{"name":"Mylan School of Pharmacy Duquesne University Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"McCrossin","sequence":"additional","affiliation":[{"name":"Mylan School of Pharmacy Duquesne University Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Kalarchian","sequence":"additional","affiliation":[{"name":"School of Nursing Duquesne University Pittsburgh Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"1260","article-title":"Ein syndrom von aidositas, kleinwuchs, kryptorchismus und oligophrenie nach myotonieartigem zustand im neugeborenenalter","volume":"86","author":"Prader A","year":"1956","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320230307"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.792"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019616-200010041-00002"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genom.2.1.153"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2008.165"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.20371"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.20370"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1352\/0895-8017(2006)111[193:MIPS]2.0.CO;2"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32133"},{"key":"e_1_2_6_12_1","first-page":"269","article-title":"Metabolic syndrome in children with Prader\u2013Willi syndrome: the effect of obesity","volume":"21","author":"Brambilla P","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199211000-00022"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320600612"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200317030-00003"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1352\/0895-8017(1999)104<0067:MBDIPS>2.0.CO;2"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2788.1998.4260463.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2788.1998.4260440.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.163.5.680"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0790966700002019"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2788.2000.00250.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19961016)65:2<133::AID-AJMG10>3.0.CO;2-R"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-7610.00025"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970211)68:4<433::AID-AJMG12>3.0.CO;2-T"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.3.565"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.31520"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30004"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.2006.00916.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2008.255"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1360"},{"key":"e_1_2_6_31_1","first-page":"20","article-title":"Interventions for weight gain in adults treated with novel antipsychotics","volume":"2","author":"Aquila R","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_32_1","first-page":"321","article-title":"Effects of olanzapine and risperidone on metabolic factors in children and adolescents: a retrospective evaluation","volume":"15","author":"Khan R","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"e_1_2_6_33_1","first-page":"23","article-title":"Mechanisms of antipsychotic\u2010induced weight gain","volume":"62","author":"McIntyre RS","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/00048670801961123"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0602"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1109"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199610000-00011"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(88)90151-7"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1999.9.239"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300327"},{"key":"e_1_2_6_41_1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":"Double\u2010blind comparison of first\u2010 and second\u2010generation antipsychotics in early\u2010onset schizophrenia and schizo\u2010affective disorder: findings from the treatment of early\u2010onset schizophrenia spectrum disorders (TEOSS) study","volume":"165","author":"Sikick L","year":"2008","journal-title":"Am J Psychiatry"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2011.0015"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10r06264yel"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124010-00005"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0204"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.102006461.x"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2009.02996.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33951"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.07.002"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.01.014"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0901"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.1558","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.1558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:44:17Z","timestamp":1761065057000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.1558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1002\/phar.1558"],"URL":"https:\/\/doi.org\/10.1002\/phar.1558","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"2015-03-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}